期刊文献+

KAI1/CD82在肠癌组织中的表达水平及表达机制 被引量:2

The expression levels of KAI1/CD82 mRNA in intestinal tumor and investigation the regulative mechanism
下载PDF
导出
摘要 目的 初探KAI1/CD82在肠癌组织中的表达水平及可能涉及的机制。方法 采用多重逆转录聚合酶链反应 ,对 18例肠癌组织和正常肠组织中KAI1/CD 82mRNA表达水平进行半定量检测。用去甲基化试剂 5 氮脱氧胞苷作用于Bel 740 2和SMMC 772 1肝癌细胞株 ,然后检测KAI1/CD82mRNA表达水平。结果 肠癌组织中KAI1/CD82mRNA表达水平 (0 .78±0 .2 2 )较正常肠组织中表达水平 (1.5 3± 0 .12 )显著降低 (P <0 .0 5 ) ,其中 5例肠癌患者有转移 ,癌组织中KAI1/CD82mRNA表达水平 (0 .70± 0 .2 4) ,与未转移组没有显著差异。 5 氮脱氧胞苷作用下 ,SMMC 772 1细胞株中KAI1/CD82mRNA表达水平基本没变 ,而Bel 740 2细胞株KAI1/CD82mRNA表达水平有一定的增高。结论 肠癌组织中KAI1/CD82mRNA表达水平较正常肠组织中表达显著降低 ,这种表达降低可能涉及到甲基化等多种复杂调控的机制。 Objective To investigate the expression levels of KAI1/CD82 mRNA in intestinal tumour and normal intestinal tissues and the regulative mechanism of KAI1/CD82 expression. Methods KAI1 mRNA of 18 cases with intestinal tumour as well as, normal intestinal tissues were detected using duplex reverse transcription polymerase chair reaction (duplex RT-PCR)method.Bel-7402 and SMMC-7721 HCC cell lines were cultured after being demethylated by 5-aza-deoxycytidine.Results The average expression levels of KAI1/CD82 mRNA in intestinal tumour tissues(0.78±0.22)were significantly by lower than that in normal intestinal tissues(1.53±0.12)P<0.05 .KAI1/CD82 expression of intestinal tumour metastasic group(0.70±0.24)weren't significantly lower than that of non-metastasic group.After being demethylated by 5-aza-deoxycytidine,the expression level of KAI1/CD82 mRNA in Bel-7402 cell increased,but could't detect significant change in SMMC-7721 cell.Conclusion The indicated KAI1/CD82 in intestinal tumor might be a marker for intestinal tumour cell migration and that several regulatory mechanisms including gene demethylation might be involved in KAI1/CD82 expression.
出处 《临床检验杂志》 CAS CSCD 北大核心 2002年第3期153-155,共3页 Chinese Journal of Clinical Laboratory Science
关键词 KAI1 CD82 肠癌 表达 SMMC-7721肝癌细胞株 5-氮脱氧胞苷 Bel-7402肝癌细胞株 KAI1/CD82 Intestinal tumor SMMC-7721 cell Bel-7402cell 5-aza-deoxycytidine
  • 相关文献

参考文献1

二级参考文献10

  • 1Leon SA,Shapiro B,Sklaroff DM,et al.Free DNA in the serum of cancer patients and the effect of therapy[].Cancer Research.1977 被引量:1
  • 2Mayall F,Jacobson G,Wilkins R,et al.Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma[].Journal of Clinical Pathology.1998 被引量:1
  • 3Chen Xq,Stroun M,Magnenat JL,et al.Microsatellite alterations in plasma DNA of small cell lung cancer patients[].Nature Medicine.1996 被引量:1
  • 4Wong IH,Lo YM,Zhang J,et al.Detection of aberrant P16 methylation in the plasma and serum of liver cancer patients[].Cancer Research.1999 被引量:1
  • 5Anker P,Lefort F,Vasioukhin V,et al.K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer[].Gastroenterology.1997 被引量:1
  • 6Castells A,Puig P,Mora J,et al.K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance[].Journal of Clinical Oncology.1999 被引量:1
  • 7Sozzi G,Musso K,Ratcliffe C,et al.Detection of microsatellite alteration in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis[].Clinical Cancer Research.1999 被引量:1
  • 8Esteller M,Sanchez Cespedes M,Rosell R,et al.Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patient[].Cancer Research.1999 被引量:1
  • 9Giacona MB,Ruben GC,Iczkowski KA,et al.Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls[].Pancreas.1998 被引量:1
  • 10Kink GD,Camus Randon AM,Mendy M,et al.Ser-249 p53 Mutations in plasma DNA of patient with hepatocellular carcinoma from The Gambin[].Journal of the National Cancer Institute.2000 被引量:1

共引文献2

同被引文献35

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部